Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases

Details for Australian Patent Application No. 2009204194 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Jure-Kunkel, Maria

Agent A J Park

Pub. Number AU-A-2009204194

PCT Pub. Number WO2009/089260

Priority 61/056,957 29.05.08 US; 61/019,778 08.01.08 US

Filing date 7 January 2009

Wipo publication date 16 July 2009

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/385 (2006.01) - having two or more sulfur atoms in the same ring

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/089260 Priority application(s): WO2009/089260

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009204198-Drain pump assembly for a dishwasher

2009204189-Disinfectant alcohol-soluble quaternary ammonium polymers